{"schema_version":"secwatch.filing_event.v1","accession":"0000842633-22-000042","form_type":"8-K","ticker":"TRS","cik":"0000842633","company_name":"TRIMAS CORP","filed_at":"2022-04-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:03.906702+00:00","generated_at":"2026-06-26T03:45:12.550016+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"TriMas Q1 net sales $224.3M (+8.5% YoY), adj. EPS $0.50; reaffirms FY2022 outlook","bullets":["Diluted EPS $0.33, adjusted diluted EPS $0.50 (up 2.0% YoY); net income $14.2M.","Specialty Products segment sales +37.5% driven by steel cylinders; Packaging +4.8%, Aerospace -0.2%.","Reaffirms FY2022 adj. EPS guidance of $2.25-$2.35, sales growth 8%-11%.","Free cash flow use of $1.9M in Q1 vs $10.3M prior year due to inventory and capex.","Acquired Intertech (prototype molds for medical) in Packaging; leverage ratio 2.0x."],"urls":{"canonical":"https://secwatch.observer/filing/0000842633-22-000042","json":"https://secwatch.observer/filing/0000842633-22-000042.json","markdown":"https://secwatch.observer/filing/0000842633-22-000042.md","text":"https://secwatch.observer/filing/0000842633-22-000042.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/842633/000084263322000042/0000842633-22-000042-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/842633/000084263322000042/trs-20220428.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T03:45:12.550016+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}